A recent study found high levels of human immunodeficiency virus type 1 (HIV-1) bound to erythrocytes in HIV-1-infected patients with long-term undetectable plasma HIV-1 loads, potentially representing a novel and important reservoir of HIV-1 infection. To attempt to confirm this finding, we purified erythrocytes from 13 HIV-1-infected patients with long-term undetectable plasma viral load and depleted contaminating CD3 +
CD4
+ lymphocytes using magnetic beads. HIV-1 load of the purified erythrocyte fraction was !20 copies/mL in 11 of 13 patients and 42 and 52 copies/mL in 2 patients. Contrary to the prior report, therefore, erythrocytes do not represent a novel reservoir of HIV-1 infection in these patients.
HIV-1 infection cannot be eradicated from patients despite long-term suppression of viremia with antiretroviral therapy (ART) because, in large part, of persistent reservoirs of infection. Persistent reservoirs that have been described include the kidney [1] , the central nervous system [1, 2] , the female and male genital tracts [3] , lymphoid organs including the gut [4] , and, most prominently, resting CD4 + lymphocytes [4] . HIV-1 has been demonstrated within circulating immune complexes (CICs) of patients who were not receiving ART [5, 6] , and subsequent studies have shown that these HIV-1-containing immune complexes can bind to erythrocytes in vitro, presumably to CR1, the abundant erythrocyte complement receptors [7, 8] . In a more recent report, Hess et al. [9] fractionated whole blood from patients receiving ART and found significantly higher levels of HIV-1 RNA in the erythrocyte fraction than in the plasma fraction of the same individuals; the differences were especially marked in patients who had plasma viral loads (VLs) !20 copies/mL. These findings, especially in those patients who had undetectable plasma viremia, would represent a novel reservoir of HIV-1 infection and suggest that there is a much larger burden of circulating infectious virus than current models of HIV-1 pathogenesis predict. We therefore attempted to confirm these findings, but we used a more efficient method of lymphocyte depletion to obtain erythrocytes of higher purity.
Patients, materials, and methods. Patients were recruited from the outpatient HIV clinic at the Mount Sinai Medical Center. Patients were enrolled under a protocol approved by the Mount Sinai School of Medicine institutional review board (IRB), and written informed consent was obtained from all patients before enrollment. Experimentation guidelines of the US Department of Health and Human Services and the Mount Sinai School of Medicine IRB were followed in the conduct of this research.
Whole blood was drawn into EDTA-anticoagulated tubes, immediately placed on ice, and separated by centrifugation at 600 g for 10 min at 4ЊC. The platelet-rich plasma and buffy coat were aspirated and discarded, and the pelleted erythrocyte fraction was washed 4 times in PBS on ice. Washed erythrocytes were depleted of CD3 + lymphocytes using magnetic beads coated with a monoclonal antibody to CD3 (Dynabeads CD3; Dynal). Erythrocytes were also purified using the protocol of Hess et al. [9] for comparison purposes. Briefly, the pelleted erythrocyte fraction was prepared as above, brought to 1% dextran final, and allowed to sediment on ice at 1 g for ∼1 h until maximal separation occurred. The supernatant and interface layer were aspirated and discarded, and the erythrocyte fraction was washed 4 times in PBS on ice.
For measurement of erythrocyte-associated HIV-1 load, an aliquot of purified erythrocytes was lysed with sterile water, and HIV-1 load quantitation was performed by the Mount Sinai Medical Center clinical laboratory on 1 mL using the Roche Amplicor kit and the ultrasensitive methodology (Roche Amplicor HIV-1 Monitor Test; version 1.5; sensitivity 20 copies/mL).
Assay for residual CD3 + CD4 + lymphocytes. Purified erythrocytes were assayed for residual contaminating CD3 + lymphocytes / number of events in gated region containing beads) ϫ (number of beads per tube / 50 mL) p absolute count of CD3 + CD4 + lymphocytes. Results. Thirteen consecutive HIV-1-infected patients who met the inclusion criterion of long-term aviremia were enrolled. Eleven patients were receiving ART, and 2 "long-term nonprogressors" were not receiving ART. The duration of aviremia and the CD4 + lymphocyte count at the time of the study for each patient are shown in table 1. Median time of aviremia (!50 copies/mL) was 48 months; median CD4 + lymphocyte count was 513 cells/mL. Dextran sedimentation of the erythrocyte fraction using the protocol of Hess et al. [9] resulted (n p 12) in significant lymphocyte contamination of the erythrocyte fraction in 70% of specimens (median residual lymphocytes, 200/mL; median depletion, 83% + lymphocyte-depleted erythrocyte fractions were indistinguishable from background (!20 copies/mL of blood) in 11 of 13 patients; only 2 patients' specimens had values over background (42 and 52 copies/mL of blood) (table 1), well within the false-positive measurement range of this polymerase chain reaction (PCR)-based HIV-1 load method. The internal quantitation standards (QS) of all samples assayed were amplified within the normal efficiency range (data not shown). In summary, we have found no evidence that there is a significant quantity of HIV-1 bound to erythrocytes in patients with long-term aviremia. We therefore conclude that erythrocytes do not represent a reservoir of HIV-1 infection in these patients.
Discussion. The implications of the presence of a pool of infectious HIV-1 particles associated with erythrocytes are significant. Erythrocytes, through surface complement receptors, bind complement-and antibody-opsinized pathogens [11] , facilitating their removal from the bloodstream by delivery to the splenic macrophages where the immune complexes are phagocytosed. HIV-1 has been demonstrated within CICs of patients who were not receiving ART [5, 6] . Subsequent studies have shown that these HIV-1-containing immune complexes can bind to erythrocytes in vitro, presumably via their abundant surface complement receptors [7, 8] , and it has been shown that levels of the complement receptor CR1 on erythrocytes from HIV-1-infected patients are significantly depressed, com- pared with healthy controls [12] , consistent with removal of the complex of CR1 CIC in the spleen. HIV-1, however, is only partially inactivated by complement or antibody binding [13] and could therefore be delivered as an infectious particle directly to an organ highly enriched with susceptible target cells for HIV-1 infection. It was therefore crucial to confirm the findings of Hess et al. [9] that erythrocytes purified from HIV-1-infected patients with undetectable plasma VL contained high levels of HIV-1 RNA, including infectious particles. What we found instead is that there was essentially no PCR-amplifiable HIV-1 RNA associated with circulating erythrocytes in 13 consecutive patients who had undetectable plasma viremia when we carefully quantitatively depleted lymphocytes from the erythrocyte fraction. Proviral HIV-1 DNA, which is present in CD3 +
+ lymphocytes of all HIV-1-infected patients regardless of duration of plasma HIV-1 load suppression [4] , is measured with at least equal efficiency as the HIV-1 RNA in viral particles in the Amplicor HIV-1 load assay. Therefore, we were careful to minimize contamination of the purified erythrocytes by CD3 + CD4 + lymphocytes to avoid obtaining spuriously high HIV-1 load measurements. We also used the dextran sedimentation technique as described by Hess et al., but in our hands there were always significant numbers of residual contaminating lymphocytes. Although this might be considered a negative finding in relationship to the report of Hess et al. [9] , we have identified no step in our simple methodology that resulted in falsely negative VL measurements. For instance, hemoglobin has been reported to inhibit PCRs [14] , but the QS of the Amplicor HIV-1 load assay was uniformly amplified to expected levels in all cases, thereby excluding the possibility of spuriously negative results due to inhibition of the assay. In summary, although we cannot fully explain the findings of Hess et al. [9] of HIV-1 associated with erythrocytes in HIV-1-infected patients in vivo, the dextran gradient sedimentation purification of erythrocytes did not result in an adequate depletion of CD3 + CD4
+ lymphocytes in our hands. We therefore believe that this report of HIV-1 associated with erythrocytes of HIV-1-infected patients in vivo [9] may have been due to undetected contamination of the erythrocytes by CD3 + CD4 + cells containing HIV-1 proviral DNA. In conclusion, we found that HIV-1 is not associated with erythrocytes in HIV-1-infected patients with long-term undetectable HIV-1 load in plasma, and therefore erythrocytes do not represent a novel reservoir of HIV-1 infection in these patients.
